IRCT20221016056201N1招募中2 期
Evaluation the effect of Linagliptin and Empagliflozin combination on glycosylated hemoglobin and fasting blood sugar control in patients with type 2 diabetes
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •patients who have been diagnosed with type 2 diabetes mellitus based on the ADA diagnostic criteria and indicated for medical therapy
- •patients who have not reached to treatment goals despite receiving previous medications
排除标准
- •type 1 diabetes
- •diabetic ketoacidosis (present and previous)
- •pancreatitis (present and previous)
- •diabetic foot ulcer (present and previous)
- •GFR less than 30
- •BMI less than 18.5
- •severe adverse drug reactions
- •lack of consent to participate in the study
- •untreated urinary tract infection
研究者
相似试验
进行中（未招募）
1 期
Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology and Metabolic Control in Patients with Type 2 Diabetes Mellitus on Stable Metformin TreatmentType 2 Diabetes MellitusEUCTR2014-004895-48-DEProfil Institut für Stoffwechselforschung GmbH
招募中
不适用
Comparison the effects of Empaglifluzin-linagliptin and Dapaglifluzin-linagliptin on HbA1c ? LDL and Albuminuria in patients with T2DMType 2 diabetes.IRCT20221221056889N1Arak University of Medical Sciences70
招募中
3 期
Effect of Linagliptin on Diabetic patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210812052156N1Gonabad University of Medical Sciences70
进行中（未招募）
不适用
Effect of Linagliptin in comparison with Glimepiride as add on to Metformin on the metabolism of diabetic patients after a meal.Diabetes mellitus type 2 on metformin therapyMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-000179-17-DEikfe GmbH
尚未招募
Unknown
Comparative in vivo evaluation of 2 Empagliflozin 10 mg Combined Linagliptin 5 mg Tablet formulations.IRCT20180620040164N69Cosar Pharmaceutical Co.24